Breathing New Life into Inhaled Nitric Oxide Delivery

GeNO is an emerging biotechnology company focused on the design, development, and commercialization of next-generation inhaled Nitric Oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions.

At GeNO, our mission is to improve the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is needed. We strive to exceed customer expectations in terms of safety, efficacy, and growth by focusing on the science, development, and commercialization of our innovations.